Genetic ophthalmology and the era of clinical care

JAMA

Volumn 297, Issue 7, 2007, Pages 733-736

  Sieving, Paul A ^a   Collins, Francis S ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLINDNESS; EYE CARE; EYE DISEASE; GENE THERAPY; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; GENETIC VARIABILITY; HEREDITY; HUMAN; MEDICAL GENETICS; NOTE; PRIORITY JOURNAL;

EYE DISEASES; GENE THERAPY; GENETIC TESTING; HUMANS; MUTATION; OPHTHALMOLOGY; VON HIPPEL-LINDAU DISEASE;

EID: 33847157342     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.7.733     Document Type: Note

References (52)

1. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007;125:151-158.
2. Stone EM. Genetic testing for inherited eye disease. Arch Ophthalmol. 2007;125:205-212.
3. Waardenburg PJ. Genetics and the human eye. In: Waardenburg PJ, Franceschetti A, Klein D, eds. Genetics and Ophthalmology. Vol 1. Assen, the Netherlands: Blackwell Scientific Publications Ltd; 1961.
4. McKusick-Nathans Institute for Genetic Medicine; Johns Hopkins University, and National Center for Biotechnology Information, National Library of Medicine. Online Mendelian Inheritance in Man (OMIM). http://www.ncbi.nlm. nih.gov/omim/. Accessed December 15, 2006.
5. RetNet. Retinal information network. http://www.sph.uth.tmc.edu/Retnet/. Accessed December 15, 2006.
6. Collins FS. No longer just looking under the lamppost. Am J Hum Genet. 2006;79:421-426.
7. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643-646.
8. Aldave AJ, Sonmez B. Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet? Arch Ophthalmol. 2007;125:177-186.
9. Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch Ophthalmol. 2007;125:165-173.
10. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol. 2007;125:30-37.
11. Ito YA, Footz TK, Murphy TC, Courtens W, Walter MA. Analyses of a novel L130F missense mutation in FOXC1. Arch Ophthalmol. 2007;125:128-135.
12. Beby F, Commeaux C, Bozon M, Denis P, Edery P, Morlé L. New phenotype associated with an Arg116Cys mutation in the CRYAA gene. Arch Ophthalmol. 2007;125:213-216.
13. Shroff NP, Cherian-Shaw M, Bera S, Abraham EC. Mutation of R116C results in highly oligomerized alpha A-crystallin with modified structure and defective chaperone-like function. Biochemistry. 2000;39:1420-1426.
14. Iyengar SK. The quest for genes causing complex traits in ocular medicine. Arch Ophthalmol. 2007;125:11-18.
15. Gorin MB. A clinician's view of the molecular genetics of age-related maculopathy. Arch Ophthalmol. 2007;125:21-29.
16. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299-1320.
17. International HapMap Project. http://www.genome.gov/10001688. Accessed December 15, 2006.
18. Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
19. Duggal P, Klein AP, Lee KE, Klein R, Klein BEK, Bailey-Wilson JE. Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study. Arch Ophthalmol. 2007;125:74-79.
20. Friedman DS, O'Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
21. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
22. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
23. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in agerelated macular degeneration. Science. 2005;308:385-389.
24. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol. 2007;125:55-62.
25. Shuler RK Jr, Hauser MA, Caldwell J, et al. Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism. Arch Ophthalmol. 2007;125:63-67.
26. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration [published ahead of print October 19, 2006]. Science. 2006;314:992-993.
27. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38:458-462.
28. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration. Arch Ophthalmol. 2006;124:995-1001.
29. DeAngelis MM, Ji F, Kim IK, et al. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol. 2007;125:49-54.
30. Genes and Environment Initiative. http://www.genome.gov/19518663. Accessed December 15, 2006.
31. Qi X, Sun L, Hauswirth WW, Lewin AS, Guy J. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol. 2007;125:268-272.
32. Recombinant DNA Advisory Committee Gene Transfer Protocol 0410-677. Phase 1 trial of ocular subretinal injection of a recombinant adeno-associated virus gene vector in patients with retinal disease due to RPE65 mutations. http://www.gemcris.od.nih.gov/Contents/GC_PRIN_INVES_RPT_VIEW.asp?WIN_TYPE= R&PID=1932&searchfield=jacobson; http://crisp.cit.nih.gov/crisp/ CRISP_LIB.getdoc?textkey=7071589&p_grant_num=1U10EY017280-01&p_query= (gene+therapy)&ticket=29833939&p_audit_session_id=197360544& p_audit_score=11&p_audit_numfound=1&p_keywords=gene+therapy. Accessed December 15, 2006.
33. Hamel CP, Tsilou E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM. Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem. 1993;268:15751-15757.
34. Redmond TM, Yu S, Lee E, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20:344-351.
35. Gu SM, Thompson DA, Srikumari CR, et al. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet. 1997;17:194-197.
36. Aguirre GD, Baldwin V, Pearce-Kelling S, Narfstrom K, Ray K, Acland GM. Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. Mol Vis. 1998;30:4-23.
37. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
38. Acland GM, Aguirre GD, Bennett J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness (published ahead of print October 14, 2005). Mol Ther. 2005;12:1072-1082.
39. American Medical Association. Survey: Genetic Testing: A Study of Consumer Attitude. Chicago, Ill: American Medical Association; 1998.
40. University of Washington, Seattle. GeneTests: Medical Genetics Information Resource (database online), 1993-2006. http://www.genetests.org. Accessed December 15, 2006.
41. Stone EM. Finding and interpreting genetic variations that are important to ophthalmologists. Trans Am Ophthalmol Soc. 2003;101:437-478.
42. Wong WT, Agrón E, Coleman HR, et al. Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis. Arch Ophthalmol. 2007;125:239-245.
43. Wu W-C, Drenser K, Trese M, Capone A, Dailey W. Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. Arch Ophthalmol. 2007;125:225-230.
44. Hamel PA, Phillips RA, Muncaster M, Gallie BL. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 1993;7:846-854.
45. Gallie BL, Zhao J, Vandezande K, White A, Chan HSL. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer. In press.
46. Downs K, Zacks DN, Caruso R, et al. Molecular testing for hereditary retinal disease as part of clinical care. Arch Ophthalmol. 2007;125:252-258.
47. Blain D, Brooks BP. Molecular diagnosis and genetic counseling in ophthalmology. Arch Ophthalmol. 2007;125:196-203.
48. National Ophthalmic Disease Genotyping Network. eyeGENE Web site. http://www.nei.nih.gov/resources/eyegene.asp. Accessed December 15, 2006.
49. Collins FS, Watson JD. Genetic discrimination: time to act. Science. 2003;302:745.
50. Database of genotype and phenotype. http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=gap. Accessed December 15, 2006.
51. Age-Related Eye Disease Study. http://www.nei.nih.gov/amd/. Accessed December 15, 2006.
52. National Institute of Neurological Disorders and Stroke (NINDS). Parkinsonism Study. http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi? id=phs000002. Accessed January 16, 2007.